Search for Clinical Trial Results

Sponsored By

Neoplasms, Basal Cell - 16 Studies Found

Status Study
Completed Study Name: CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial
Condition:
  • Carcinoma, Basal Cell
  • Carcinoma, Squamous Cell
  • Skin Neopla
    Date: 2009-02-18
    Interventions:
    • Drug: 5-fluorouracil Apply thi
Completed Study Name: Use of Otoscope as a Non-Invasive Tool for Diagnosis of Pilomatricoma
Condition: Pilomatrixoma
Date: 2008-07-11
Completed Study Name: Clinical Trial Comparing Tissue Adhesive Vs. Absorbable Suture Vs. Non-Absorbable Suture
Condition:
  • Cyst of Face, Neck or Shoulder
  • Pilomatrixoma of Face, Neck or Shoulder

Date: 2006-02-15
Interventions: Device: standard suture (5-0 prolene), topical skin adhesive (dermabond), absorbable suture (5-0 Chromic gut)
Not yet recruiting Study Name: Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Date: 2016-12-26
Interventions: Drug: Vismodegib 1 capsule (150 mg vismodegib) taken once daily for a maximum of 12 weeks.
Completed Study Name: Vismodegib on Locally Advanced and Metastatic Basal Cell Carcinoma Under Real World Conditions
Condition: Metastatic Basal Cell Carcinoma
Date: 2016-04-24
Completed Study Name: Topical Itraconazole in Treating Patients With Basal Cell Cancer
Condition: Skin Basal Cell Carcinoma
Date: 2016-03-31
Interventions:
  • Drug: Itraconazole Applied top
Not yet recruiting Study Name: Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer
Condition: Skin Basal Cell Carcinoma
Date: 2016-03-01
Interventions:
  • Drug: Arsenic Trioxide Given P
Recruiting Study Name: Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer
Condition: Skin Basal Cell Carcinoma
Date: 2016-02-12
Interventions:
  • Other: Laboratory Biomarker Analysis

Completed Study Name: Observational Study to Determine the Effectiveness and Safety of Vismodegib in Patients With Locally Advanced Basal Cell Carcinoma (laBCC)
Condition: Locally Advanced Basal Cell Carcinoma
Date: 2016-02-02
Interventions: Drug: Vismodegib Dosing of Vismodegib in accordance with local clinical practice and local labeling
Active, not recruiting Study Name: Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC)
Condition: Basal Cell Carcinoma
Date: 2016-01-20
Interventions: Drug: ERIVEDGE Other Name: VISMODEGIB
Next >>>